Meraviglia, S <br/><br/>
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.  [electronic resource] 

 -  Clinical and experimental immunology  Aug 2010 
 - 290-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2010.04167.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--adverse effects<br/>Aged<br/>Breast Neoplasms--blood<br/>Cell Proliferation--drug effects<br/>Chemokines--blood<br/>Cytokines--blood<br/>Diphosphonates--adverse effects<br/>Disease Progression<br/>Esterases--metabolism<br/>Female<br/>Hemiterpenes--pharmacology<br/>Humans<br/>Imidazoles--adverse effects<br/>Immunotherapy--methods<br/>Interferon-gamma--metabolism<br/>Interleukin-2--adverse effects<br/>Leukocyte Common Antigens--metabolism<br/>Lymphocyte Activation--drug effects<br/>Lymphocyte Count<br/>Lysine--analogs & derivatives<br/>Middle Aged<br/>Mucin-1--blood<br/>Organophosphorus Compounds--pharmacology<br/>Receptors, Antigen, T-Cell, gamma-delta--metabolism<br/>Remission Induction<br/>Salvage Therapy<br/>T-Lymphocyte Subsets--cytology<br/>TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>Treatment Outcome<br/>Tumor Necrosis Factor Receptor Superfamily, Member 7--metabolism<br/>Zoledronic Acid